Zealand Pharma A/S (LON:0NZU)
London · Delayed Price · Currency is GBP · Price in DKK 498.12
+6.58 (1.34%)
At close: Dec 3, 2025
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 4.06 billion as of December 3, 2025. Its market cap has decreased by -28.70% in one year.
Market Cap
4.06B
Enterprise Value
2.22B
Revenue
1.07B
Ranking
n/a
PE Ratio
5.31
Stock Price
498.12
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 159.84M to 4.06B, an increase of 2,440.25%. That is a compound annual growth rate of 24.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 4.06B | -27.77% |
| Dec 30, 2024 | 5.62B | 121.65% |
| Dec 29, 2023 | 2.54B | 105.19% |
| Dec 30, 2022 | 1.24B | 74.70% |
| Dec 30, 2021 | 707.55M | -33.54% |
| Dec 30, 2020 | 1.06B | 9.92% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.56B |
| HSBC Holdings | 185.11B |
| Shell | 161.08B |
| Unilever | 113.50B |
| British American Tobacco p.l.c. | 95.88B |
| Rio Tinto Group | 92.93B |
| Rolls-Royce Holdings | 86.80B |
| GSK plc | 72.32B |